It is with great pleasure that we introduce Prof Clare Scott who will take on the role of ANZGOG Chair from 31 March 2022.

Introducing Prof Clare Scott

Prof Clare Scott is Joint Division Head, Clinical Translation, (Cancer) at the Walter and Eliza Hall Institute of Medical Research, and Chair, Gynaecological Cancer, Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne, and Medical Oncologist at Peter MacCallum Cancer Centre. She has 15+ years’ experience in clinical cancer genetics, including working in Familial Cancer Clinics and in treating breast and ovarian cancer. In the lab, she focuses on ovarian biology, including the role of apoptosis in infertility and on developing targeted therapies for ovarian cancer in novel ovarian cancer models. In 2021, Prof Scott was awarded the Medical Oncology Group of Australia (MOGA) and Novartis Oncology Cancer Achievement Award.

Prof Scott has been a member of ANZGOG since 2009 and a Board Director since 2014. She is currently the Chair of the OASIS Steering Committee, and holds the position of Co-Chair, Gynaecologic Cancer Intergroup (GCIG) Rare Tumour Committee.

Message from Assoc Prof Philip Beale – Outgoing Chair

“It has been a true honour and a privilege to serve as the chair of ANZGOG for the past 4 years building on the giant shoulders of the past chairs.

The organisation is in very good shape to move ahead over the next 5 years and I have every confidence that Clare Scott will lead the organisation to new heights.

I personally want to thank all of the ANZGOG staff and the Board members for all their support during my time as Chair.

I wish everyone all the best and hopefully we can provide the platform for more clinical trials to achieve better treatments for women with gynaecological cancers. I will not be stopping my involvement in ANZGOG and will see many of you at upcoming committee meetings, educational activities and next year’s ASM in Queensland.”

Video of our interview with Clare Scott

We were able to catch up with Prof Scott at the ANZGOG Annual Scientific Meeting last week in Melbourne to ask her about her main goals as Chair, her plans for ANZGOG’s stakeholders, and the importance of translational research. See the interview below: